Literature DB >> 8925666

Fabrication of a keratoprosthesis.

M G Doane1, C H Dohlman, G Bearse.   

Abstract

For patients with opaque corneas that have a poor prognosis when using regular corneal transplants, a clear plastic "window" in the form of a keratoprosthesis may offer the only hope of usable vision. Various forms of such devices have been used for many years with varying degrees of success. The design, fabrication, and optical testing of two variations of a polymethylmethacrylate (PMMA) keratoprosthesis are described. Type 1 consists of a twin-plate collarbutton-style design that is used in eyes that have sufficient tear fluid production to maintain wetting of the anterior surface of the eye. Type 2 is of a similar design, with an added anterior cylinder that protrudes through a permanently closed eyelid, and is used in end-stage dry eyes.

Entities:  

Mesh:

Year:  1996        PMID: 8925666     DOI: 10.1097/00003226-199603000-00011

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  16 in total

1.  Boston type 1 keratoprosthesis: the New York Eye and Ear experience.

Authors:  A P Patel; E I Wu; D C Ritterband; J A Seedor
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

Review 2.  Development of hydrogel-based keratoprostheses: a materials perspective.

Authors:  David Myung; Pierre-Emile Duhamel; Jennifer R Cochran; Jaan Noolandi; Christopher N Ta; Curtis W Frank
Journal:  Biotechnol Prog       Date:  2008-04-19

3.  Anatomical survival and visual prognosis of Boston type I keratoprosthesis in challenging cases.

Authors:  Maria Fideliz de la Paz; Josef Stoiber; Valeria de Rezende Couto Nascimento; Juan Alvarez de Toledo; Orang Seyeddain; Wolfgang Hitzl; Günther Grabner; Rafael I Barraquer; Ralph Michael
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-25       Impact factor: 3.117

4.  Microkeratome assisted deep lamellar keratoprosthesis.

Authors:  S Shimmura; H Miyashita; Y Uchino; T Taguchi; H Kobayashi; J Shimazaki; J Tanaka; K Tsubota
Journal:  Br J Ophthalmol       Date:  2006-04-05       Impact factor: 4.638

5.  Presumed endophthalmitis following Boston keratoprosthesis treated with 25 gauge vitrectomy: a report of three cases.

Authors:  Ilias Georgalas; Anastasios J Kanelopoulos; Petros Petrou; Ioannis Ladas; Eustratios Gotzaridis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-12       Impact factor: 3.117

6.  High-resolution spectral domain anterior segment optical coherence tomography in type 1 Boston keratoprosthesis.

Authors:  Brett L Shapiro; Dennis E Cortés; Eric K Chin; Jennifer Y Li; John S Werner; Ellen Redenbo; Mark J Mannis
Journal:  Cornea       Date:  2013-07       Impact factor: 2.651

7.  Bioactive interpenetrating polymer network hydrogels that support corneal epithelial wound healing.

Authors:  David Myung; Nabeel Farooqui; Luo Luo Zheng; Wongun Koh; Sarita Gupta; Amit Bakri; Jaan Noolandi; Jennifer R Cochran; Curtis W Frank; Christopher N Ta
Journal:  J Biomed Mater Res A       Date:  2009-07       Impact factor: 4.396

8.  Optical functional properties of the Boston Keratoprosthesis.

Authors:  Rony R Sayegh; Linda Avena Diaz; Fernando Vargas-Martín; Robert H Webb; Claes H Dohlman; Eli Peli
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-08       Impact factor: 4.799

9.  Three-dimensional anterior segment imaging in patients with type 1 Boston Keratoprosthesis with switchable full depth range swept source optical coherence tomography.

Authors:  Raju Poddar; Poddar Raju; Dennis E Cortés; John S Werner; Mark J Mannis; Robert J Zawadzki
Journal:  J Biomed Opt       Date:  2013-08       Impact factor: 3.170

10.  Boston type I keratoprosthesis-donor cornea interface evaluated by high-definition spectral-domain anterior segment optical coherence tomography.

Authors:  Ana G Alzaga Fernandez; Nathan M Radcliffe; Kimberly C Sippel; Mark I Rosenblatt; Priyanka Sood; Christopher E Starr; Jessica B Ciralsky; Donald J D'Amico; Szilárd Kiss
Journal:  Clin Ophthalmol       Date:  2012-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.